cas 1396843-52-9|| where to buy 2-cyclobutaneamido-N-[5-(ethylsulfanyl)-1,3,4-thiadiazol-2-yl]-1,3-oxazole-4-carboxamide

Produktname:2-cyclobutaneamido-N-[5-(ethylsulfanyl)-1,3,4-thiadiazol-2-yl]-1,3-oxazole-4-carboxamide

IUPAC Name:2-cyclobutaneamido-N-[5-(ethylsulfanyl)-1,3,4-thiadiazol-2-yl]-1,3-oxazole-4-carboxamide

: CAS：1396843-52-9; Molekulare Formel：C13H15N5O3S2; Reinheit：95%+

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1396843-52-9 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:1396843-52-9; Molekulare Formel:C13H15N5O3S2; Schmelzpunkt:-; SMILES-Code:CCSC1=NN=C(NC(=O)C2=COC(NC(=O)C3CCC3)=N2)S1; Dichte:

: Katalognummer:CM840803; Molekulargewicht:353.42; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Oxazoles; Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

: Thiadiazoles; Thiadiazoles are a subfamily of azoles. Structurally, they are five-membered heterocyclic compounds containing two nitrogen atoms and one sulfur atom, and two double bonds, forming an aromatic ring. Depending on the relative positions of the heteroatoms, there are four possible structures; these forms do not interconvert and are therefore structural isomers rather than tautomers. These compounds themselves are rarely synthesized and have no particular utility, however, compounds that use them as structural motifs are fairly common in pharmacology.